American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Cancer Program Practice Profile Reports (CP3R)

The Web-based Cancer Program Practice Profile Reports (CP3R) offer local providers comparative information to assess adherence to and consideration of standard of care therapies for major cancers. This reporting tool provides a platform from which to promote continuous practice improvement to improve quality of patient care at the local level and also permits hospitals to compare their care for these patients relative to that of other providers. The aim is to empower clinicians, administrators, and other staff to work cooperatively and collaboratively to identify problems in practice and delivery and to implement best practices that will diminish disparities in care across Commission on Cancer (CoC)-accredited cancer programs.

Current CP3R measures:

  • Radiation therapy is administered within one year (365 days) of diagnosis for women under age 70 receiving breast conserving surgery for breast cancer.
  • Combination chemotherapy is considered or administered within four months (120 days) of diagnosis for women under age 70 with AJCC T1cN0M0 or Stage II or III hormone receptor negative breast cancer.
  • Tamoxifen or third generation aromatase inhibitor is considered or administered within one year (365 days) of diagnosis for women with AJCC T1cN0M0 or Stage II or III hormone receptor positive breast cancer.
  • Radiation therapy is considered or administered following any mastectomy within 1 year (365 days) of diagnosis of breast cancer for women with ≥ 4 positive regional lymph nodes.
  • Image or palpation-guided needle biopsy (core or FNA) is performed to establish diagnosis of breast cancer.
  • Breast conservation surgery rate for women with AJCC clinical stage 0, I, or II breast cancer.
  • At least 12 regional lymph nodes are removed and pathologically examined for resected colon cancer.
  • Adjuvant chemotherapy is considered or administered within four months (120 days) of diagnosis for patients under the age of 80 with AJCC Stage III (lymph node positive) colon cancer.
  • Radiation therapy is considered or administered within six months (180 days) of diagnosis for patients under the age of 80 with clinical or pathologic AJCC T4N0M0 or Stage III and who are receiving surgical resection for rectal cancer.
  • At least 15 regional lymph nodes are removed and pathologically examined for resected gastric cancer.
  • At least ten (10) regional lymph nodes are removed and pathologically examined for AJCC stage IA, IB, IIA, and IIB resected NSCLC.
  • Systemic chemotherapy is administered within 4 months to day preoperatively or day of surgery to 6 months postoperatively, or it is considered for surgically resected cases with pathologic, lymph node-positive (pN1) and (pN2) NSCLC.

CP3R Overview

CP3R (v3) Navigation

CP3R Measure Specifications

Cancer Program Standards 2012: Ensuring Patient Centered Care introduced two standards that require CoC-accredited cancer programs to achieve specified levels of performance for defined measures of care. This document identifies those measures of care and the expected performance rates for those measures and how compliance with these standards will be assessed.

The CP3R require a login, and can be accessed through the CoC’s Datalinks portal.